Foamix Pharmaceuticals Ltd.

FY: Dec 31 2019

Q: Sep 30 2019

Q: Jun 30 2019

Q: Mar 31 2019

FY: Dec 31 2018

Q: Sep 30 2018

Q: Jun 30 2018

Q: Mar 31 2018

FY: Dec 31 2017

FY: Dec 31 2017

FY: Dec 31 2016

FY: Dec 31 2015

FY: Dec 31 2014

2.02,7.01,9.01

1.01,2.01,3.01,3.03,5.01,5.02,5.03,8.01,9.01

5.07,8.01,9.01

7.01,9.01

8.01,9.01

2.03

8.01

1.01,9.01

1.01,8.01,9.01

2.02,7.01,9.01

8.01,9.01

1.01,7.01,9.01

8.01,9.01

8.01,9.01

7.01,9.01

8.01,9.01

1.01,9.01

2.02,7.01,9.01

8.01,9.01

1.01,2.03,3.02,8.01,9.01

Notice of Effectiveness

Certification of termination of registration of a class of securities (Section 12(b))

Post Effective Amendment to S-8

Post-effective amendment to a registration statement

Post Effective Amendment to S-8

Post Effective Amendment to S-8

Post Effective Amendment to S-8

Notification of removal from listing and/or registration on a national securities exchange

Written communication about a business combination transaction (Rule 425)

Written communication about a business combination transaction (Rule 425)

Written communication about a business combination transaction (Rule 425)

Written communication about a business combination transaction (Rule 425)

Written communication about a business combination transaction (Rule 425)

Written communication about a business combination transaction (Rule 425)

Written communication about a business combination transaction (Rule 425)

Written communication about a business combination transaction (Rule 425)

Written communication about a business combination transaction (Rule 425)

Written communication about a business combination transaction (Rule 425)

Written communication about a business combination transaction (Rule 425)

Written communication about a business combination transaction (Rule 425)

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

No description available

Definitive Proxy Statement

No description available

Preliminary Proxy Statement

Definitive Proxy Statement

STERN STANLEY

Domzalski David

Hirsch Stanley

Bruno Anthony D

BARBARI SHARON SURREY

Bright Rex

KAZANCHYAN ANNA

Harsch Mutya

Schwartz Aharon

Stuart Iain

Wiley Matthew T.

Hadar Ilan

Schwartz Aharon

STERN STANLEY

Wiley Matthew T.

Harsch Mutya

Domzalski David

Bruno Anthony D

Hirsch Stanley

KAZANCHYAN ANNA

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

No description available

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

No description available

Draft registration statement (confidential submission) (amendment)